Loss of the Metalloprotease ADAM9 Leads to Cone-Rod Dystrophy in Humans and Retinal Degeneration in Mice
David Parry(AstraZeneca (United Kingdom)), Chris F. Inglehearn(University of Leeds), Kelly Springell(St James's University Hospital), Carmel Toomes(University of Leeds), Jacquelyn Bond(University of Leeds), Carl Blobel(Hospital for Special Surgery), Martin McKibbin(Leeds Teaching Hospitals NHS Trust), Clare V. Logan(University of Leeds), Manir Ali(University of Leeds), Dror Sharon(Hebrew University of Jerusalem), Colin A. Johnson(University of Leeds), Steven Swendeman(Boston Children's Hospital), Eyal Banin(Hebrew University of Jerusalem), Matthew Adams(St James's University Hospital), Eric A. Pierce(Broad Institute), Yasmin Abdul Rashid(King Edward Medical University), Lauren L. Daniele(Thomas Jefferson University), Edward N. Pugh(Membrane Technology & Research (United States)), Michael Danciger, Samuel G. Jacobson(Penn Presbyterian Medical Center), Katherine V. Towns(St James's University Hospital), Adam Booth(Derriford Hospital), Hussain Jafri(Pakistan Army), Tim M. Strom(Ludwig-Maximilians-Universität München), Debora B. Farber(Doheny Eye Institute), L. Bida(Hadassah Medical Center), Rebecca K. Chance(Penn Presbyterian Medical Center)
Cited by 91
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets
|Nature Genetics|1995|1.1k
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
|Proceedings of the National Academy of Sciences|1995|1k